-+ 0.00%
-+ 0.00%
-+ 0.00%

FDA Accepts Biofrontera sNDA Filing for Ameluz PDT in Superficial Basal Cell Carcinoma

Reuters·02/11/2026 14:15:16

Please log in to view news